| Stage | AMKR | % of rev | NVDA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.0B | 100.00% | $96.2B | 100.00% | NVDA ×48.34 |
| Gross profit | $364M | 18.26% | $72.1B | 74.98% | NVDA +56.7pp |
| Operating income | $225M | 11.29% | $63.7B | 66.24% | NVDA +54.9pp |
| Pre-tax income | $230M | 11.56% | $71.5B | 74.32% | NVDA +62.8pp |
| Net income | $191M | 9.59% | $59.7B | 62.03% | NVDA +52.4pp |
| Stage | AMKR | NVDA | Gap · A − B |
|---|---|---|---|
| Revenue | $2.0B100.00% | $96.2B100.00% | NVDA ×48.34 |
| Gross profit | 18.26%$364M | 74.98%$72.1B | NVDA +56.7pp |
| Operating income | 11.29%$225M | 66.24%$63.7B | NVDA +54.9pp |
| Pre-tax income | 11.56%$230M | 74.32%$71.5B | NVDA +62.8pp |
| Net income |
| 9.59%$191M |
| 62.03%$59.7B |
| NVDA +52.4pp |
No shared counterparties.